ANI Pharmaceuticals Announces Two Generic Product Launches

BAUDETTE, Minn., March 27, 2019 -- (Healthcare Sales & Marketing Network) -- ANI Pharmaceuticals, Inc. ("ANI" or the "Company") (Nasdaq: ANIP) today announced the launch of 18mg and 27mg Methylphenidate Hydrochloride Extended-Release T... Biopharmaceuticals, Generics, Product Launch ANI Pharmaceuticals, Methylphenidate, Attention Deficit Hyperactivity Disorder
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news